CELLeBRAIN
CELLeBRAIN is a start-up company developing “Cell & Gene Therapies” to address challenging medical conditions. Our proprietary platform technologies employ mesenchymal stem cells (MSCs) engineered to express diverse therapeutic genes to treat sold cancers and chronic fibrotic diseases. Our allogeneic gene & cell therapy products are formulated as off-the shelf, frozen form to meet the high demand in the global market with substantial quantities of doses. Our therapeutic products have met the rigorous Chemistry, Manufacturing, and Controls (CMC) requirements of the Korean FDA and received clinical trial approval after demonstrating its safety and efficacy through non-clinical GLP studies.
Seeking partners, investors
Our therapeutic cells provide innovative modalities that combine the benefits of gene therapy and stem cell therapy, while overcoming the limitations of both. We are currently in the process of raising Series B funding and are seeking co-development partners and strategic investors for an IPO.
- For more information, visit: https://cellebrain.com
